Companies › SPRY

ARS PHARMACEUTICALS INC (SPRY)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001671858 · EDGAR filings · Updated 2026-07-27

ARS PHARMACEUTICALS INC (SPRY) has reported institutional ownership of 94.0%, with 202 institutional managers holding positions valued at $751.2M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Current report (8-K) filed
• 2026-07-14 — SCHEDULE 13G/A filed
• 2026-07-07 — Current report (8-K) filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-06-26 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARS PHARMACEUTICALS INC has 202 institutional holders and institutional ownership of 94.0%.

Insider activity

Insiders reported 27 transactions (0 buys, 15 sells) across 11 reporting insiders, with a net reported value of −$21.9M.

Data flags from SEC filings

Related companies

EVOMMUNE INC (EVMN) · PHATHOM PHARMACEUTICALS INC (PHAT) · HARROW INC (HROW) · SCHRODINGER INC (SDGR) · GERON CORP (GERN) · IRADIMED CORP (IRMD)